Cargando…
Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease
Alcohol-associated liver disease (AALD) is a major cause of liver disorders worldwide. Current treatment options are limited, especially for AALD-associated fibrosis. Promising approaches include RNA interference for miR-155 overexpression in Kupffer cells (KCs), as well as the use of CXCR4 antagoni...
Autores principales: | Zhang, Chuhan, Hang, Yu, Tang, Weimin, Sil, Diptesh, Jensen-Smith, Heather C., Bennett, Robert G., McVicker, Benita L., Oupický, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949580/ https://www.ncbi.nlm.nih.gov/pubmed/35336043 http://dx.doi.org/10.3390/pharmaceutics14030669 |
Ejemplares similares
-
Reduction in Obesity-Related Hepatic Fibrosis by SR1664
por: McVicker, Benita L., et al.
Publicado: (2023) -
A Selective PPARγ Modulator Reduces Hepatic Fibrosis
por: McVicker, Benita L., et al.
Publicado: (2020) -
Novel Anti-fibrotic Therapies
por: McVicker, Benita L., et al.
Publicado: (2017) -
Alcohol-induced tubulin post-translational modifications directly alter hepatic protein trafficking
por: Adhikari, Raghabendra, et al.
Publicado: (2023) -
Role of cell-free network communication in alcohol-associated disorders and liver metastasis
por: Kuracha, Murali R, et al.
Publicado: (2021)